Table 6 ANOVA of APP levels vs. oligomer treatments in multiple cell lines.

From: Human microRNA (miR-20b-5p) modulates Alzheimer’s disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer’s biomarkers

Effect

F (df, df)

p

D

Treatment

6.39 (6, 90)

<0.001

0.188

Cell Line

0.32 (7, 90)

0.926

<0.001

Treatment × Line

3.15 (20, 90)

<0.001

0.214

Back to article page